Cindy Berejikian
Directeur des opérations chez MINERALYS THERAPEUTICS, INC.
Profil
Cindy Berejikian is currently the Executive Vice President-Operations at Mineralys Therapeutics, Inc. She previously worked as the Director & Global Program Manager at Amgen, Inc. and as the Vice President-Program Management at Otonomy, Inc. Ms. Berejikian holds an MBA degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Santa Barbara.
Postes actifs de Cindy Berejikian
Sociétés | Poste | Début |
---|---|---|
MINERALYS THERAPEUTICS, INC. | Directeur des opérations | - |
Anciens postes connus de Cindy Berejikian
Sociétés | Poste | Fin |
---|---|---|
AMGEN INC. | Directeur/Membre du Conseil | - |
OTONOMY | Corporate Officer/Principal | - |
Formation de Cindy Berejikian
University of California, Los Angeles | Masters Business Admin |
University of California, Santa Barbara | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MINERALYS THERAPEUTICS, INC. | Health Technology |
AMGEN INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Otonomy, Inc.
Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |